Search
Ciprofibrate is a phenoxyacetic acid lipid-lowering drug, which is a new type of lipid-lowering drug.
Ciprofibrate competitively inhibits HMG-CoA reductase, reducing cholesterol synthesis; Increase the number of LDL receptors on the surface of hepatocytes, so that hepatocytes clear LDL cholesterol increased; Increase protease activity and increase very low-density lipoprotein clearance; Reduce blood viscosity, anticoagulant, antiplatelet aggregation, increase plasmin action, improve microcirculation.
Product Name | Ciprofibrate |
Apperance | White or almost white crystalline powder |
EINECS | 257-744-6 |
MF | C13H14Cl2O3 |
MW | 289.16 |
Assay | ≥99.0% |
Product parameters | |
Cas number: | 52214-84-3 |
Appearance: | White or almost white crystalline powder |
Purity: | 99% min |
Package details: | 25kg/drum |
Brand: | Fortunachem |
Guaranteed the purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: